Immunolocalization of oestrogen and progesterone receptors in prostatic hyperplasia and carcinoma

Histopathology

Volumn 28, Issue 2, 1996, Pages 163-168

  Hikamatsu, M ^a   Maehara, I ^a   Orikasa, S ^a   Sasano, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinoma; Hyperplasia; Oestrogen receptor; Progesterone receptor; Prostate

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

EID: 0030053334     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.280326.x     Document Type: Article

References (15)

1. Schulze H, Claus S. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. The Prostate 1990; 16; 331-343.
2. Brolin J, Skoog L, Ekman P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant prostatic tissue. The Prostate 1992; 20; 281-295.
3. Mobbs BG, Johnson IE, DeSombre ER, Toth J, Hughes A. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, anti-estrogen and progesterone. Cancer Res. 1987; 47; 2645-2651.
4. Mobbs BG, Johnson IE, Liu Y. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays. The Prostate 1990; 16; 235-244.
5. Harper ME, Sibley PEC, Francis AB, Nicholson RI, Griffiths K. Immunocytochemical assays for estrogen receptors applied to human prostatic tumors. Cancer Res. 1986; 46(suppl.); 4288-4290.
6. Mobbs BG, Liu Y. Immunohistochemical localization of progesterone receptor in benign and malignant human prostate. The Prostate 1990; 16; 245-251.
7. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Human Pathol. 1994; 25; 530-535.
8. Masood S, Lu L, Rodenroth S. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors. Modern Pathol. 1990; 3; 724-728.
9. Japanese Urological Association. (The 2nd edition) General Rules for Clinical and Pathological Studies on Prostatic Cancer. The Japanese Pathological Society, 1992.
10. Watanabe K, Sasano H, Harada N et al. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am. J. Pathol. 1995; 146; 491-500.
11. Wolf RM, Schneider SL, Pontes EJ et al. Estrogen and progestin receptor in human prostatic carcinoma. Cancer 1985; 55; 2477-2481.
12. Ekman P, Barrack ER, Greene GL, Jensen EV, Walsh PC. Estrogen receptors in human prostate: Evidence for multiple binding sites. J. Clin. Endocrinol. Metab. 1983; 57; 166-176.
13. Santti R, Newbold RR, Makela S, Pylkkanen L, McLachlan JA. Development of estrogenization and prostatic neoplasia. The Prostate 1994; 24; 67-78.
14. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dlom G. Investigation of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on a immunuhistochemical basis. Virchows Arch [A]. 1988; 412; 387-591.
15. West NB, Roselli CE, Resko JA, Greene GL, Brenner RM. Estrogen and progestin receptors and aromatase activity in rhesus monkey prostate. Endocrinology 1988; 123; 2312-2322.